Crossmark

Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth

Crossref DOI link: https://doi.org/10.1080/2162402X.2018.1480286

Published Online: 2018-07-11

Published Print: 2018-09-02

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Ekiz, Huseyin Atakan https://orcid.org/0000-0001-7718-6841
Lai, Shu-Chin Alicia https://orcid.org/0000-0002-8164-7484
Gundlapalli, Harika

Haroun, Fadi

Williams, Matthew A.

Welm, Alana L. https://orcid.org/0000-0002-1412-1351
Funding

Funding for this research was provided by:

California Breast Cancer Research Program (BC113194)

DOD Breast Cancer Research Program (BC113194)

Susan G Komen Foundation (SAC160078)
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=koni20

Publication History

Received: 2017-12-19

Revised: 2018-05-17

Accepted: 2018-05-20

Published: 2018-07-11